TnSAM Chapter Monthly Meetings
Please contact Dr. Zotos or ASAM membership for dates and times.
A Zoom invitation will be sent to members upon request.
TNSAM Represented at the 55th Annual ASAM Conference in Dallas Texas
Reflecting on the Success of the 55th Annual ASAM Conference
The 55th Annual ASAM Conference, held at the Gaylord Texan Resort & Convention Center in Grapevine, Texas, was a resounding success. Under the theme “Innovations in Addiction Medicine and Science,” this year’s event showcased a range of breakthroughs and ongoing developments in the field of addiction...
DEA and HHS joint letter on Medications for Opioid Use Disorder (MOUD)
DEA’s Diversion Control Division is pleased to post this joint letter from DEA and HHS supporting the expansion of Medications for Opioid Use Disorder (MOUD). DEA and HHS support the expansion of MOUD especially in rural or underserved areas.
DEA is asking its registrants to ensure an adequate and uninterrupted supply of MOUD products when appropriately prescribed and asks...
Crisis in East Tennessee: The Alarming Surge of Tranquilizer-Related Deaths
Greetings from the Tennessee Society of Addiction Medicine, where we are deeply committed to addressing the critical issues surrounding addiction within our state. In this article by Vinay Simlot, which can be found here in its original format and context, we explore a pressing concern that has recently come to light, as reported by WBIR: the tragic rise in tranquilizer-related deaths...
Mitigating Risks from Human Xylazine Exposure
This document offers a comprehensive overview of a vital meeting titled “Mitigating Risks from Human Xylazine Exposure.” Hosted by the Reagan-Udall Foundation for the FDA, the meeting features expert speakers from prestigious organizations, including the White House Office of National Drug Control Policy and the U.S. Food and Drug Administration. The meeting’s agenda...
Congratulations to Dr. Sumrok- Region X Board Member
Congratulations to Dr. Daniel Sumrok, M.D., FAAFP, DFASAM, on his appointment as ASAM’s Region X Board Member. This prestigious position is a testament to his unwavering commitment to the field of Addiction Medicine and his remarkable contributions to the community. In this article, we will delve into the significance of Dr. Sumrok’s role and his dedication to advancing...
Tennessee Society of Addiction Medicine (TNSAM) Statement on Workplace Safety in Medical Practices
TNSAM represents addiction medicine physicians dedicated to providing the best medical care to patients afflicted with substance use disorders. We recognize that high-quality care can only be achieved in an environment where healthcare workers feel secure and protected. Recent reports and discussions highlight an urgent need to address workplace safety concerns affecting healthcare...
TMA Day on the Hill
The Tennessee Society of Addiction Medicine Participated in the Tennessee Medical Association Day on the Hill Event
Nashville, TN -March 7, 2023
The Tennessee Society of Addiction Medicine (TNSAM) proudly took part in TMA’s prestigious annual policy briefing and lobby day in Nashville, leaving an indelible mark on the landscape of addiction medicine. This highly...
HB309/SB1072 Decriminalization of Marijuana
February 27, 2023
The Honorable Clay Doggett
Chair
House Subcommittee on Criminal Justice
1st Floor, State Capitol
600 Dr. Martin L. King, Jr. Blvd.
Nashville, TN 37243
Re: TNSAM’s Support for HB309/SB1072
Dear Chair Doggett,
On behalf of the Tennessee Society of Addiction Medicine (TNSAM), the medical specialty society representing physicians and clinicians in Tennessee who specialize in the...
DEA Announces Proposed Rules for Permanent Telemedicine Flexibilities
DEA extends many telemedicine flexibilities adopted during the COVID-19 PHE with appropriate safeguards
WASHINGTON – Today, the Drug Enforcement Administration announced proposed permanent rules for the prescribing of controlled medications via telemedicine, expanding patient access to critical therapies beyond the scheduled end of the COVID-19 public health emergency. The...
DEA Announces Important Change to Registration Requirement
Dear DEA Registrant:
On December 29, 2022, with the signing of the Consolidated Appropriations Act of 2023 (the Act), Congress eliminated the “DATA-Waiver Program.”
DEA fully supports this significant policy reform. At this moment, when the United States is suffering tens of thousands of opioid-related drug poisoning deaths every year, the DEA’s top priority is doing everything in...